https://www.youtube.com/watch?v=fO0mTS8hFRc On September 20th, 2021, Frier Levitt partner Anthony Mahajan, Esq. presented an Ethics CLE webinar as part of the September Conference for the ACC New Jersey (Association of Corporate Counsel)  He... Read More
Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | Webinars | White Collar Criminal Defense & Government Investigations

As we approach the 10 year anniversary of enactment of the DSCSA and move toward the final complex interoperable electronic tracking phase, every pharmacist needs to be aware of the effects this legislation has on the pharmaceutical supply chain. ... Read More
Blogs & Articles | Community, Retail Pharmacies | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

On August 9, 2021, the Food and Drug Administration (FDA) announced it would delay enforcement of the 5% limit on out-of-state shipments of compounded prescriptions until October 27, 2022. States that sign the MOU commit to investigating,... Read More
Blogs & Articles | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | Traditional Compounding Pharmacies (503A)

On July 9, 2021, President Biden issued an executive order (EO) containing 72 directives to more than a dozen federal agencies, many of which have broad implications for healthcare. Specifically targeted are healthcare competition, hospital mergers,... Read More
Blogs & Articles | Healthcare | Healthcare Law | Hospitals and Healthcare Systems | In-house Counsel Legal Support Services | Life Sciences | Pharmaceutical Manufacturers | Pharmacy Law | Pharmacy Transactions | Physician Dispensing | Physicians and Medical Practices of all Specialties | Professional Practice Representation | Regulatory Compliance, including FDA, DEA and HIPAA

State legislative initiatives to regulate Pharmacy Benefit Managers (“PBMs”) have gained momentum.  Arkansas successfully defended its state PBM regulation in 2020 before the United States Supreme Court.  Now, more states have been enacting... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

During the past year, the COVID-19 pandemic has illuminated, more than ever before, the critical role government agencies have in virtually all aspects of our lives, including public health. The Freedom of Information Act (“FOIA”), 5 U.S.C. §... Read More
Blogs & Articles | COVID-19 Resources | Healthcare Law | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

Inventory maintenance, a routine undertaking in most businesses, is among the most crucial tasks performed by pharmacists and may have profound repercussions if not handled accurately.  In particular, inventory shortages are common discrepancies... Read More
Blogs & Articles | Community, Retail Pharmacies | Defending Pharmacies in PBM Audits | Life Sciences | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Criminal Defense & Government Investigations

Increasing complexities in the pharmaceutical supply chain have led to challenges in the purchase and distribution of pharmaceutical products directly to medical practices. While the traditional role of MSOs is centralization of administrative and... Read More
Blogs & Articles | Healthcare | Life Sciences | Management Services Organizations (MSO) | Pharmaceutical Manufacturers | Pharmaceutical Wholesalers | Pharmacy Law | Regulatory Compliance, including FDA, DEA and HIPAA

In a prior article, we addressed mandatory exclusions from federally funded health care programs for certain criminal convictions, and the importance of "thinking globally" while resolving a criminal investigation. Put another way, collateral... Read More
Blogs & Articles | Healthcare | Healthcare Law | Regulatory Compliance, including FDA, DEA and HIPAA | White Collar Defense and Government Investigation